As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
Following the approval by the shareholders of the 3rd resolution at the Shareholders' Meeting on 26/10/2017, the company issued redeemable share warrants (BSAR C).